US President Donald Trump has frequently recommended the use of hydroxychloroquine in order to fight against widespread Covid-19 on various occasions during his daily press briefings. The supposed drug is being used in a number of countries for the treatment of Malaria. The Washington Post reported that CIA employees have warned about Donald Trump’s suggested anti-malaria coronavirus treatment drug could potentially have life-threatening side effects, including sudden death. It is noteworthy that the CIA workforce was warned against the drug on a website for CIA employees with questions related to the spread of coronavirus, in late March 2020. The report further said, “At this point, the drug is not recommended to be used by patients except by medical professionals prescribing it as part of ongoing investigational studies”.
The report of WP added, “There are potentially significant side effects, including sudden cardiac death, associated with hydroxychloroquine and its individual use in patients need to be carefully selected and monitored by a health care professional”. Point to be noted that the memo was posted in response to an employee’s inquiry as to whether they should take the drug without a prescription. It said, “Please don’t obtain this medication on your own”. The CIA hasn’t yet issued a comment on internal workforce communications. Trump’s approval to use the anti-malaria drug has proved highly controversial over the past month.
President Trump praised the combination of hydroxychloroquine in late March with an antibiotic known as azithromycin as a possible way out for the US against coronavirus. It is important that the US death toll has crossed 26,000 with 580,000 confirmed positive cases. So, the United States now has the most confirmed cases of Covid-19 disease in the world. Trump said earlier this month, he said, “I want them to try it, and it may work and it may not work. But if it doesn’t work, there is nothing lost by doing it. What do you have to lose”? Moreover, medical experts continue to insist there is no concrete scientific evidence of the drug’s effectiveness or safety when used for coronavirus patients.